Association of PTPN22 gene (rs2488457) polymorphism with ulcerative colitis and high levels of PTPN22 mRNA in ulcerative colitis

International Journal of Colorectal Disease

Volumn 28, Issue 10, 2013, Pages 1351-1358

  Chen, Zhitao ^a   Zhang, Heng ^a   Xia, Bing ^b,c,d   Wang, Ping ^a   Jiang, Ting ^a   Song, Min ^a   Wu, Jie ^a  

^a CENTRAL HOSPITAL OF WUHAN   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Clinical Research Center for Intestinal and Colorectal Diseases of Hubei Province   (China)

^d Key Laboratory of Allergy and Immune related Diseases   (China)

Author keywords

Levels; Polymorphism; Protein tyrosine phosphatase nonreceptor type 22; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; MESSENGER RNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PTPN22 GENE; ULCERATIVE COLITIS;

ADULT; ALLELES; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RNA, MESSENGER;

EID: 84884976575     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1671-3     Document Type: Article

References (30)

1. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434
2. Behrens TW (2011) Lyp breakdown and autoimmunity. Nat Genet 43:821-822
3. Zhang J, Zahir N, Jiang Q et al (2011) The autoimmune disease-associated PTPN22 variant promotes calpain-mediated LYP/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 43:902-907
4. Cloutier JF, Veillette A (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189:111-121
5. Wu S, Bottini M, Rickert RC et al (2009) In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation. ChemMedChem 4:440-444
6. Xie Y, Liu Y, Gong G et al (2008) Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase. Bioorg Med Chem Lett 18:2840-2844
7. Stanford SM, Mustelin TM, Bottini N (2010) Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases. Semin Immunopathol 32:127-136
8. Dultz G, Matheis N, Dittmar M et al (2009) The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 19:143-148
9. Bottini N, Vang T, Cucca F et al (2006) Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 18:207-213
10. Chung SA, Criswell LA (2007) PTPN22: its role in SLE and autoimmunity. Autoimmunity 40:582-590
11. Diaz-Gallo LM, Espino-Paisán L, Fransen K et al (2011) Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 17:2287-2294
12. Kawasaki E, Awata T, Ikegami H et al (2006) Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 140:586-593
13. Liu F, Liu J, Zheng TS et al (2012) The -1123G>C variant of PTPN22 gene promoter is associated with latent autoimmune diabetes in adult Chinese Hans. Cell Biochem Biophys 62:273-279
14. Huang JJ, Qiu YR, Li HX et al (2012) A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chinese. Rheumatol Int 32:767-771
15. Feng X, Li YZ, Zhang Y et al (2010) Association of the PTPN22 gene (-1123G>C) polymorphism with rheumatoid arthritis in Chinese patients. Tissue Antigens 76:297-300
16. Orrú V, Tsai SJ, Rueda B et al (2009) A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 18:569-579
17. Rodríguez-Rodríguez L, Taib WR, Topless R et al (2011) The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum 63:365-372
18. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6
19. Satsangi J, Silverberg MS, Vermeire S et al (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749-753
20. Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 2:1041-1048
21. Chang HH, Tai TS, Lu B et al (2012) PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis. PLoS One 7:e33067
22. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108
23. Inoue A, Takahashi KA, Arai Y et al (2006) The therapeutic effects of basic fibroblast growth factor contained in gelatin hydrogel microspheres on experimental osteoarthritis in the rabbit knee. Arthritis Rheum 54:264-270
24. Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI et al (2011) Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis 17:963-970
25. Viken MK, Olsson M, Flåm ST et al (2007) The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens 70:190-197
26. Jostins L, Ripke S, Weersma RK et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119-124
27. Mori M, Yamada R, Kobayashi K et al (2005) Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50:264-266
28. Ronninger M, Guo Y, Shchetynsky K et al (2012) The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls. Genome Med 4:2
29. Wu J, Katrekar A, Honigberg LA et al (2006) Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem 281:11002-11010
30. Jüliger S, Bongartz M, Luty AJ et al (2003) Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics 54:675-680